...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Potential Suitor
4
Sep 11, 2020 10:18PM
4
Sep 12, 2020 06:09PM
7
Sep 12, 2020 07:11PM
9
Sep 12, 2020 09:00PM
4
Sep 13, 2020 08:03AM
3
Sep 13, 2020 08:33AM

Thanks for your post paladin. Just to clarify regarding Boehringer Ingelheim and Lilly, if interested they likely would be acting together as they are co-owners of the SGLT2 inhibitor Jardiance. Given Christoph Boehringer's sizeable indirect holding in RVX I think it makes this possibility interesting. 

On a related topic, it would be great if RVX might summarize, if possible, if patients in BoM on an SGLT2 inhibitor experienced fewer or lessened side effects when also on Apabetalone.  

1
Sep 13, 2020 11:19AM
4
Sep 13, 2020 03:07PM
1
Sep 13, 2020 04:53PM
Share
New Message
Please login to post a reply